Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangjishi capsule in primary hyperlipidemia
CTR20131195Phase 2Active
- Sponsor
- Jilin Jianbang Pharmaceutical Technology Development
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mangosteen extract in hyperlipidemia (HLD), sponsored by Jilin Jianbang Pharmaceutical Technology Development. Started Apr 2015; status: active.
02
Drugs
mangosteen extract
03
Conditions
hyperlipidemia (HLD)
Beyond the preview
Go deeper on CTR20131195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131195.